Thanks goleftmassa, found it.
Bobbust (or anyone else), can you please explain why they refer to the price of gas when stating that they expected a loss for H2. I looked at their website and I see that the energy they provide is 100% renewable, i.e. no gas is involved. I thought maybe they meant electricity only, but they say energy not electricity. In addition, they also indicate they use 56% of bio generated energy, which I assume is biogas. So all these confuse me in terms of why they refer to the prices of natural gas and why milder weather decreases their anticipated loss. Thank you.
So they had 19,000 at the end of the period. They had a funding round after that. So considering this and assuming the same cash burn as last year (around 700k), is it correct to say that they should have cash at least until next September?
Let's say PAT eventually gets around 400-500mln (playing on the safe side here). This is still 40X + from current price. Given the RNS text and moves made, they should think that the probability of winning is 90%+. Expected return is huge. Even if you have to wait 3-5 years. This is more than one can hope to get from investing (unless very lucky). The price will move up along as the case progresses, so even after one year expect this to be significantly up from today. This is not to mention the possibility of an agreement. If it happens even at a lower than expected payment the annual return will be huge.
Yes, it has more cash than its MC, but it burns at least 1mln a month, and probably more than that. In addition, I'd like to have a look at the accounts payable. If there is no turn around (high probability given the history and the current macro), it will have to raise money pretty soon. Given no one was interested to take it over, at what price they'll have to raise the money?
I have been a Tern shareholder and I still watch it. So the company more than doubled its revenues this year to 19 mln, which is a nice progress. I would have liked some info on the expected profits though. Judging by the last three years Tern had on average 30 mln operating loss (39mln last year). If this trajectory holds they will be again in a substantial loss (I guess that's why no visibility on the losses given?). The only other quick way to judge the value is to look at the PS ratio which is about 30 and points to a huge overvaluation of the company. Assuming a 100% growth in revenues Tern will need about 4 years to get a more or less acceptable value on this metric. But the question is if that enormous growth is feasible to be sustained over this period. I think it is easier for the price to come down. My view is that I like the progress here, but will wait for an acceptable price.
They project revenues of £1.52m-£1.75m while loss is £15.5m. The MK is £19m. The US advertising companies average price to sales ratio is 1.5 (FTSE media companies have it at 1.3). They'll need years to get their PS ratio in line even if they can sustain high levels of growth. Do they have these years given the amount of loss and the money that will be needed to sustain the activity? It seems that at this point in time Mirriad is highly overvalued.
Thanks, makes sense.
Assuming that the today's RNS caused the price to go up, can someone explain why it is happening? I thought that the RNS at best should have left the price at the yesterday's levels as it was about a delay. Or my assumption is wrong and the price goes up for other reasons? I just want to check if I did not misunderstand the RNS. Thanks.
Does the loan suggest that they don't expect the payment from G to be made Jan-Feb? Otherwise, why arranging this loan facility?
Rajbury, I've just had a look at VOX. I assume you add the stock to a watchlist to receive notifications on RNS? I created a watchlist but how can I delete a stock from there? I see only add and delete the whole watchlist buttons.
It's a deja vue of 19 January?
So in 2020 they achieved pretty similar to 2019 revenue level while oil prices were considerably lower . If the current oil price stays the same and they have same production levels, than the revenue for this year should be in the region of the current market cap. With no debt and good amount of cash this only indicates that the sp should go much higher than the current levels.
MBJ, and the buying does not seem to stop. I think we'll have a record volume today. Good luck with your investment as well.
MBJ, since the placement we've traded approximately the number of shares placed. So I think we are roughly done with the placement shares.
Steve, in the last two months we've already traded more than 5 billion. So do you not think that market can swallow the placement shares if good news?
Researchers at Ichilov Hospital in Tel Aviv said the drug EXO-CD24, which was being developed to treat cancer, resulted in 29 of 30 trial patients recovering from Covid. Professor Nadir Arber from Ichilov Hospital’s Integrated Cancer Prevention Center, who has also been part of the drug’s development, said that the hospital had tested the medication on Covid-19 patients in serious and moderate condition.
Out of the 30 patients who were administered EXO-CD24, 29 showed an improvement in two days and were discharged from the hospital within three to five days. One patient took longer to recover.
The prospectus is from September, so unlikely it is what it makes the price go up in Poland.